FDA Accepts sBLA For Bimekizumab-Bkzx in 3 New Spondyloarthr

The 3 bimekizumab indications include psoriatic arthritis, non-radiographic axial spondyloarthritis, and ankylosing spondylitis.

Related Keywords

Japan , Emmanuel Caeymaex , Hidradenitis Suppurativa , Union Chimique Belge , Immunology Solutions , International Hidradenitis Suppurativa Severity Score System , Study Participants With Moderate , Severe Hidradenitis Suppurativa , European Hidradenitis Suppurativa ,